Amgen has a lot riding on an experimental obesity drug that it hopes will rival those of Eli Lilly and Novo Nordisk. But one ...

GSK Plc’s experimental drug to treat a common inflammatory nasal condition showed positive results in two late-stage trials ...

Jasper Therapeutics, a biotech looking to make stem cell transplants less taxing and to treat immune-mediated diseases, ...

Preclinical research in fruit flies and cell cultures suggests that a dual-targeting drug could help prevent the accumulation ...

Denali Therapeutics said on Thursday its partner Sanofi has discontinued a mid-stage study testing their experimental drug to ...

Roche's experimental oral drug for breast cancer giredestrant could enter a market worth at least 10 billion Swiss francs ($12 billion) a year if it clears two key trials on early treatment of the ...

The preliminary findings prompted an early halt to a major study on the drugs and a decision to prioritize their use in Congo, where a yearlong outbreak has killed more than 1,800 people.

For 22 years, Jason Mazzola’s life was defined by a genetic condition that can cause autism and intellectual disability. Then ...

Pfizer Inc.'s experimental drug for cancer weight loss was shown to help patients regain weight in a mid-stage study, offering fresh promise for treating the dangerous muscle-wasting condition.

Sage Therapeutics said on Tuesday it would discontinue the development of its experimental drug for Alzheimer's disease as it ...

Oct 7 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said on Monday it has discontinued a late-stage study testing its experimental drug to treat a type of bladder cancer as the drug did not ...